Status:
RECRUITING
Evaluation of Muscle Involvement in Systemic Sclerosis
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Muscle involvement is poorly described in patients with systemic sclerosis (SSc) . The prevalence of muscle damage is evaluated at 5-95 % of SSc patients, particularly due to variable definitions dep...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients with systemic sclerosis according to 2013 ACR/EULAR classification criteria
Exclusion
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06051773
Start Date
January 1 2024
End Date
December 31 2024
Last Update
August 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Paul Decker
Nancy, France